⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16070362 | 0.73 | — | — | |
| SCHEMBL14641650 | 0.69 | LMNA (0.31) | — | |
| SCHEMBL13705935 | 0.69 | — | — | |
| SCHEMBL1905514 | 0.67 | — | — | |
| SCHEMBL16199849 | 0.66 | FOLH1 (0.50) | — | |
| SCHEMBL1334923 | 0.65 | — | — | |
| SCHEMBL6470561 | 0.64 | — | — | |
| SCHEMBL18862808 | 0.64 | SLC22A6 (0.39) | — | |
| SCHEMBL879224 | 0.64 | — | — | |
| SCHEMBL12487494 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1392 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727950-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS | GlaxoSmithKline Intellectual Property Development Ltd (GB) | 2026-04-22 | — | — | EP | claimed |
| EP-4121058-B1 | OXAZOLIDINONE COMPOUND AND ITS USE THEREOF AS AN ANTIBACTERIAL AGENT | MERCK SHARP & DOHME LLC (US) | 2026-02-18 | — | — | EP | claimed |
| US-12459933-B2 | Compounds and methods of use thereof as antibacterial agents | MERCK SHARP & DOHME LLC (US) | 2025-11-04 | — | — | US | claimed |
| US-12435077-B2 | Oxazolidinone compound and methods of use thereof as an antibacterial agent | MERCK SHARP & DOHME LLC (US) | 2025-10-07 | — | — | US | claimed |
| US-20250302926-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTINOMYCETIA INFECTIONS | ENDOLYTIX TECH INC (US) | 2025-10-02 | — | — | US | claimed |
| US-20250249079-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTINOMYCETIA INFECTIONS | ENDOLYTIX TECHNOLOGY, INC. | 2025-08-07 | — | — | US | claimed |
| US-12365656-B2 | Oxazolidinone compounds and methods of use thereof as antibacterial agents | MERCK SHARP & DOHME LLC (US) | 2025-07-22 | — | — | US | claimed |
| WO-2025096791-A1 | A NOVEL COMPOUND ACTING AGAINST A SELECT GROUP OF BACTERIA | NORTHEASTERN UNIVERSITY (US) | 2025-05-08 | — | — | WO | claimed |
| US-20250129084-A1 | Compounds | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2025-04-24 | — | — | US | claimed |
| EP-4518840-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTINOMYCETIA INFECTIONS | Endolytix Technology, Inc. (US) | 2025-03-12 | — | — | EP | claimed |
| EP-1115417-A2 | METHODS FOR ADMINISTRATION OF ANTIBIOTICS | Cubist Pharmaceuticals, Inc. (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2001044272-A2 | DAPTOMYCIN ANALOGS AS ANTIBACTERIAL AGENTS | CUBIST PHARMACEUTICALS, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| WO-2001044274-A1 | LIPOPEPTIDES AS ANTIBACTERIAL AGENTS | CUBIST PHARMACEUTICALS, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| WO-2001044271-A2 | DAPTOMYCIN ANALOGS AND THEIR USE AS ANTIBACTERIAL AGENTS | CUBIST PHARMACEUTICALS, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| US-6054133-A | Anti-microbial targeting for intracellular pathogens | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-04-25 | — | — | US | claimed |
| WO-2000018419-A2 | METHODS FOR ADMINISTRATION OF ANTIBIOTICS | CUBIST PHARMACEUTICALS, INC. (US) | 2000-04-06 | — | — | WO | claimed |
| CN-1244660-A | CO sensor and its producing method | FIGARO ENG (JP) | 2000-02-16 | — | — | CN | claimed |
| US-5858410-A | Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution | MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (DE) | 1999-01-12 | — | — | US | claimed |
| CN-1134278-A | Aerosol for preventing and curing pulmonary tuberculosis and its preparing method and synergy method | CONG FANZI (CN) | 1996-10-30 | — | — | CN | claimed |
| US-5104875-A | Mycobacterial infection; aids | FATOL ARZNEIMITTEL GMBH (DE) | 1992-04-14 | — | — | US | claimed |